Internal Medicine, Cardiovascular Disease · Mobile, AL
NPI
1477593663
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
6701 Airport Blvd, Suite D-330
Mobile, AL, 36608
Phone (251) 607-9797
Groups this clinician bills Medicare through
Medicare paid, 2024
$564K
12,830 services
Medicare patients, 2024
1,397
Average age 76
Drug cost, 2024
$1.4M
12,939 prescriptions
Company payments, 2025
$173
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Glenn A Cochran was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 6,725 times for 79 patients. In total Glenn A Cochran billed 12,830 services in 58 codes, and Medicare paid $564K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 6,725 | 79 | $0.10 | $675 |
| 99214 Office E&M - Established | Office | 1,348 | 889 | $77.90 | $105K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,097 | 752 | $10.74 | $12K |
| 93000 Electrocardiogram | Office | 752 | 669 | $8.07 | $6,071 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 608 | 152 | $5.12 | $3,116 |
| 99232 Hospital E&M - Subsequent | Facility | 324 | 195 | $55.01 | $18K |
| A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 287 | 144 | $228.87 | $66K |
| 93306 Echocardiography (TTE/TEE) | Office | 229 | 218 | $121.38 | $28K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 176 | 21 | $43.71 | $7,693 |
| 93015 Electrocardiogram | Office | 162 | 161 | $47.63 | $7,716 |
| 78431 Myocardial Perfusion Scan | Office | 144 | 144 | $1,600.73 | $231K |
| 99204 Office E&M - New | Office | 104 | 104 | $103.67 | $11K |
| 85610 Clinical Chemistry | Office | 99 | 28 | $4.20 | $416 |
| 99223 Hospital E&M - Initial | Facility | 92 | 89 | $115.91 | $11K |
| 82565 Clinical Chemistry | Office | 77 | 76 | $4.95 | $381 |
By year: 2022 $734K for 12,953 services; 2023 $725K for 12,638 services; 2024 $564K for 12,830 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 99 | 28 | $4.20 | $416 |
| 82565 Clinical Chemistry | 77 | 76 | $4.95 | $381 |
Medicare prescription drug claims, 2024
In 2024, the drug Glenn A Cochran prescribed most often to Medicare patients was Carvedilol, with 839 prescriptions and refills. In total Glenn A Cochran wrote 12,939 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carvedilol Generic | 839 | 2,034 | 243 | $5,557 |
| Rosuvastatin Calcium Generic | 782 | 2,105 | 250 | $13K |
| Atorvastatin Calcium Generic | 622 | 1,612 | 189 | $5,729 |
| Amlodipine Besylate Generic | 601 | 1,431 | 179 | $3,388 |
| Eliquis Apixaban | 537 | 782 | 111 | $451K |
| Clopidogrel Clopidogrel Bisulfate | 516 | 1,345 | 164 | $6,183 |
| Metoprolol Succinate Generic | 442 | 1,075 | 131 | $5,407 |
| Losartan Potassium Generic | 427 | 1,081 | 140 | $3,748 |
| Hydrochlorothiazide Generic | 402 | 934 | 118 | $1,209 |
| Furosemide Generic | 396 | 899 | 142 | $1,561 |
| Lisinopril Generic | 381 | 961 | 122 | $2,535 |
| Metoprolol Tartrate Generic | 345 | 790 | 108 | $2,305 |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 290 | 672 | 89 | $2,189 |
| Ranolazine Er Ranolazine | 289 | 579 | 82 | $26K |
| Amiodarone Hcl Generic | 252 | 477 | 82 | $4,430 |
Brand drugs: 1,394 claims; generic drugs: 11,545 claims; opioid claims: 29.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Glenn A Cochran $173 ($173 in general payments such as food, travel and fees) from 6 companies. The largest payer was Merck Sharp & Dohme LLC with $64.08.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.